Yi-yu Ke

TPQ 11571, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Author Correction: Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Journal: EMBO molecular medicine

Published: April 03, 2025

Stroma-targeted gene delivery for efficient immunogene therapy against pancreatic cancer.

Stroma-targeted gene delivery for efficient immunogene therapy against pancreatic cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: February 23, 2025

Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarcinoma Cells.

Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarcinoma Cells.

Journal: Cells

Published: May 30, 2024

Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus.

Discovery of a Long Half-Life AURKA Inhibitor to Treat MYC-Amplified Solid Tumors as a Monotherapy and in Combination with Everolimus.

Journal: Molecular cancer therapeutics

Published: September 09, 2023

Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity.

Journal: EMBO molecular medicine

Published: September 01, 2023

Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease.

Discovery of tetrasubstituted thiophenes as Cisd2 activators: A potential novel therapeutic option in nonalcoholic fatty liver disease.

Journal: European journal of medicinal chemistry

Published: March 20, 2023

Benzo[b]thiophene-2-carboxamides as novel opioid receptor agonists with potent analgesic effect and reduced constipation.

Benzo[b]thiophene-2-carboxamides as novel opioid receptor agonists with potent analgesic effect and reduced constipation.

Journal: European journal of medicinal chemistry

Published: June 30, 2022

Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.

Characterization of a mutated KCNJ5 gene, G387R, in unilateral primary aldosteronism.

Journal: Journal of molecular endocrinology

Published: August 18, 2021

Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.

Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.

Journal: Bioorganic chemistry

Published: August 06, 2021

Chemoproteomic profiling reveals cellular targets of nitro-fatty acids.

Chemoproteomic profiling reveals cellular targets of nitro-fatty acids.

Journal: Redox biology

Published: June 14, 2021

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins.

Discovery and Synthesis of a Pyrimidine-Based Aurora Kinase Inhibitor to Reduce Levels of MYC Oncoproteins.

Journal: Journal of medicinal chemistry

Published: May 19, 2021

Repurposing old drugs as antiviral agents for coronaviruses.

Repurposing old drugs as antiviral agents for coronaviruses.

Journal: Biomedical journal

Published: May 08, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026